{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:44:38Z","timestamp":1765079078983},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.leukres.2004.08.006","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T16:26:12Z","timestamp":1103127972000},"page":"331-341","source":"Crossref","is-referenced-by-count":33,"title":["Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Daniel A.","family":"Vallera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Todhunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqun","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Sicheneder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Panoskaltsis-Mortari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent D.","family":"Vallera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2004.08.006_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/14712598.2.8.785","article-title":"Recombinant fusion toxins for cancer treatment","volume":"2","author":"Kreitman","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.leukres.2004.08.006_bib2","series-title":"The collected papers of Paul Erlich, vol. 3","author":"Himmelweit","year":"1960"},{"key":"10.1016\/j.leukres.2004.08.006_bib3","first-page":"175","article-title":"Anti-CD3 antibodies","volume":"59","author":"Chatenoud","year":"1993","journal-title":"Immunol Ser"},{"key":"10.1016\/j.leukres.2004.08.006_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(78)90099-5","article-title":"One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell","volume":"15","author":"Yamaizumi","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2004.08.006_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1128\/MMBR.39.1.54-85.1975","article-title":"Diphtheria toxin: mode of action and structure","volume":"39","author":"Collier","year":"1975","journal-title":"Bacteriol Rev"},{"issue":"16","key":"10.1016\/j.leukres.2004.08.006_bib6","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1016\/S0021-9258(19)68883-6","article-title":"Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2","volume":"256","author":"Oppenheimer","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2004.08.006_bib7","doi-asserted-by":"crossref","first-page":"11885","DOI":"10.1016\/S0021-9258(19)38482-0","article-title":"Structure\/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells","volume":"265","author":"Williams","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2004.08.006_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4049\/jimmunol.136.1.93","article-title":"Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen","volume":"136","author":"Youle","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(84)92847-2","article-title":"Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease","volume":"1","author":"Filipovich","year":"1984","journal-title":"Lance"},{"key":"10.1016\/j.leukres.2004.08.006_bib10","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood.V88.6.2342.bloodjournal8862342","article-title":"Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor","volume":"88","author":"Vallera","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.08.006_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/protein\/10.9.1071","article-title":"Renal dysfunction accounts for the dose limiting toxicity of DT390anti-CD3sFv, a potential new recombinant anti-GVHD immunotoxin","volume":"10","author":"Vallera","year":"1997","journal-title":"Protein Eng"},{"key":"10.1016\/j.leukres.2004.08.006_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood.V96.3.1157","article-title":"Molecular modification of a recombinant anti-CD3epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model","volume":"96","author":"Vallera","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.08.006_bib13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/protein\/14.12.1035","article-title":"Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion","volume":"14","author":"Thompson","year":"2001","journal-title":"Protein Eng"},{"key":"10.1016\/j.leukres.2004.08.006_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/protein\/6.8.989","article-title":"An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability","volume":"6","author":"Whitlow","year":"1993","journal-title":"Protein Eng"},{"key":"10.1016\/j.leukres.2004.08.006_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/eji.1830110412","article-title":"Distinctive functional characteristics of human \u201cT\u201d lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody","volume":"11","author":"Beverley","year":"1981","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0008-8749(89)90359-6","article-title":"The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies","volume":"118","author":"Li","year":"1989","journal-title":"Cell Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib17","first-page":"2771","article-title":"Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies","volume":"52","author":"Kasprzyk","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2004.08.006_bib18","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1073\/pnas.89.13.5867","article-title":"Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin","volume":"89","author":"Batra","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2004.08.006_bib19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ijc.2910420527","article-title":"Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas","volume":"42","author":"Shen","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2004.08.006_bib20","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1038\/sj.onc.1206779","article-title":"Biologic and therapeutic role of HER2 in cancer","volume":"22","author":"Menard","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2004.08.006_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.bmt.1703524","article-title":"The use of radioimmunoconjugates in stem cell transplantation","volume":"29","author":"Pagel","year":"2002","journal-title":"Bone Marrow Transp"},{"key":"10.1016\/j.leukres.2004.08.006_bib22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(95)00105-0","article-title":"Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies","volume":"32","author":"Kurucz","year":"1995","journal-title":"Mol Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib23","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1182\/blood.V86.7.2732.2732","article-title":"Vallera DA: A murine cytokine toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells","volume":"86","author":"Chan","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.08.006_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-1759(96)00127-5","article-title":"Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies","volume":"197","author":"Vallera","year":"1996","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.leukres.2004.08.006_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood.V87.2.827.bloodjournal872827","article-title":"Lethal murine graft-versus-host disease induced by donor gamma\/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens","volume":"87","author":"Blazar","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.08.006_bib26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007890-198904000-00008","article-title":"Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients","volume":"47","author":"Abramowicz","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.leukres.2004.08.006_bib27","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.4049\/jimmunol.144.8.2875","article-title":"Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo","volume":"144","author":"Flamand","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/eji.1830200308","article-title":"Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation","volume":"20","author":"Ferran","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib29","first-page":"225","article-title":"Related direct activation of murine resting T cells by con A or anti-CD3 Ig","volume":"4","author":"Quintans","year":"1989","journal-title":"J Mol Cell Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/protein\/14.12.1035","article-title":"Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion","volume":"14","author":"Thompson","year":"2001","journal-title":"Protein Eng"},{"key":"10.1016\/j.leukres.2004.08.006_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4049\/jimmunol.136.1.93","article-title":"Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen","volume":"136","author":"Youle","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib32","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood.V83.12.3815.3815","article-title":"In vivo blockade of CD28\/CTLA4: B7\/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibillity complex (MHC) barrier in mice","volume":"83","author":"Blazar","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2004.08.006_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-3083.1994.tb03488.x","article-title":"Catabolism of the murine IgG1 molecule: evidence that both CH2\u2013CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice","volume":"40","author":"Kim","year":"1994","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0161-5890(93)90067-L","article-title":"Insertion of constant region domains of human IgG1 into CD4-PE40 increases its plasma half-life","volume":"30","author":"Batra","year":"1993","journal-title":"Mol Immunol"},{"key":"10.1016\/j.leukres.2004.08.006_bib35","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/00007890-200205270-00023","article-title":"T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice","volume":"73","author":"Weetall","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.leukres.2004.08.006_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0378-5173(01)00684-6","article-title":"Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study","volume":"221","author":"van Oosterhout","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.leukres.2004.08.006_bib37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00007890-199909270-00019","article-title":"In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9","volume":"68","author":"Huang","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.leukres.2004.08.006_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-1759(98)00123-9","article-title":"The use of an anti-CD3 immunotoxin to prevent the development of lymphoproliferative disease in SCID\/PBL mice","volume":"218","author":"Clinchy","year":"1998","journal-title":"J Immunol Methods"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212604002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T22:29:44Z","timestamp":1682893784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212604002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0145212604002942"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2004.08.006","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}